3月4日 - ** 总部位于宾夕法尼亚州的医疗技术公司Neuronetics STIM.O股价上涨8.2%，至4.61美元
** 根据LSEG汇编的数据，该公司预计 (link)，2025年收入在1.45亿美元到1.55亿美元之间，高于分析师估计的9355万美元。
** 该公司提供治疗重度抑郁症的NeuroStar设备(MDD)，第四季度营收为2249万美元，高于分析师预计的1963万美元。
** 在过去 12 个月中，STIM 下跌了 41.5
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.